Replies to post #6170 on Arbutus Biopharma Corporation (ABUS)

[mick]

$ABUS [main , catalyst patent infringement by $MRNA & companies.] i think mrna 100% cure !!!!!

no mos or info long long last....

[mick]

i imagine $ABUS wants lots !!!!! good scenario

re;
Heck of a day and bulls won the battle at 4.54.

Looking great as we continue to make steady gains without any major breakout catalyst news.

MRNA numbers are staggering for sales in 2021= 500 million to 1 billion vaccine doses.

2% royalties on that alone is worth more than ABUS market cap. I am seeing a buyout more than a royalty and licensing deal.

Makes more sense financially for Moderna IMO.

Do an all cash buyout and protect the complete Moderna pipeline to include their Covid 19 vaccine.

As soon as they sell their first dose, damages are a part of the lawsuit by ABUS or Genevant.

Why spend all that money on lawyers and time litigating when ABUS can still be bought cheap?

[mick]

$ABUS WOW FOR DIS INFRINGEMENT OF PATENTS MRNA CONTINUES TO GLOW !!!!!

MRNA
MarketWatch • 2 hours ago
U.S. buys another 100 million COVID-19 vaccine candidate doses: Moderna